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S10 Diabetic Nephropathymatrix protein accumulation were used to assess diabetic kidney damage.
Blood pressure was determined by tail-cuff method. Endothelium selective
SIRT1 knockout was generated by crossing the floxed SIRT1 mice with
SCLCreER, and recombination was induced by tamoxifen. Podocyte selective
SIRT1 knockouts were generated by crossing the floxed SIRT1 mice with
Podocin-Cre.
Results: In the diabetic kidney, SIRT1 expression was significantly reduced.
In mice with one allele of SIRT1 deletion, urinary albumin excretion was
markedly increased by 4 fold compared with SIRT1 intact mice. Renal histol-
ogy showed mesangial expansion in the diabetic SIRT1 heterozygotes; Sirius
red staining revealed more fibrosis, and qPCR indicated higher expression of
PAI-1, aSMA, Col 18aI, Loxl2 gene in diabetic SIRT1 heterozygotes compared
with wild type control. Meanwhile, losing one allele of SIRT1 did not alter
blood pressure in the diabetic mice. To further examine the mechanism,
endothelium and podocyte SIRT1 was selectively deleted respectively.
Following STZ challenge, the podocyte SIRT1 deficient mice showed higher
albuminuria and developed diabetic kidney damage without blood pressure
change. In contrast, diabetic endothelium SIRT1 deletion did not have signif-
icant change in albuminuria and kidney damage compared with wild type.
Conclusion: SIRT1 deficiency, especially in the podocyte is responsible for
the development of albuminuria and renal fibrosis. The mechanism by which
podocyte SIRT1 protects the kidney from diabetic kidney damage remains to
be explored.http://dx.doi.org/10.1016/j.hkjn.2015.08.033
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by Regulating AMPK/NOX4/ROS Signaling
Ting He, Jinghong Zhao
Department of Nephrology, Institute of Nephrology of Chongqing and Kidney
Center of PLA, Xinqiao Hospital, Third Military Medical University,
Chongqing, China
Objective: Renal interstitial fibrosis is a major pathologic feature of diabetic
nephropathy, while the pathogenesis and therapeutic interventions of dia-
betic renal interstitial fibrosis are not well established. This study investi-
gated the renoprotective effects of resveratrol and its underlying
mechanisms in diabetic renal fibrosis.
Methods: Renal fibroblast (NRK-49F) cells were pre-incubated with resvera-
trol before exposure to high glucose or normal glucose for 48 hours. We
measured cell proliferation and differentiation, reactive oxygen species
(ROS) production, nicotinamide adenine dinucleotide phosphate oxidase
(NOX) and AMP-activated protein kinase (AMPK) activity in renal fibroblast
cells. We further examined whether resveratrol-treated type 2 diabetic
db/db mice were resistant to the development of renal fibrosis. Phospho-
AMPK and NOX expression in the kidney were also assessed.
Results: High glucose is capable of inducing renal fibroblast cell proliferation
and differentiation to myofibroblasts, manifested by increased expressions
of a-SMA and fibronectin. The proliferation and myofibroblastic activation
of renal fibroblast cells induced by high glucose is accompanied by an in-
crease in the intracellular levels of ROS derived from the up-regulation of
NOX4. Resveratrol, like the NOX inhibitor diphenyleneiodonium, can mark-
edly inhibit high glucose-induced fibroblast proliferation and activation by
reducing NOX4-derived ROS production. It is then revealed that the increase
in the expression of NOX4 after high glucose treatment is due to the inacti-
vation of AMPK, which can be reversed by resveratrol. Further in vivo inves-
tigation shows that resveratrol treatment significantly attenuates renal
fibrosis in type 2 diabetic mice, accompanied by an up-regulation of phos-
pho-AMPK and a down-regulation of NOX4.
Conclusion: Our results suggest that high glucose can directly promote renal
fibroblast proliferation and activation in a ROS-dependent manner, and
resveratrol is a potential therapeutic agent against diabetic renal fibrosis
via regulation of AMPK/NOX/ROS signaling.http://dx.doi.org/10.1016/j.hkjn.2015.08.034
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Objective: Renal tubular apoptosis is a key event in initiating kidney damage
in DN. Heterogeneity of macrophage phenotype and function ultimately de-
termines the outcome of diabetic nephropathy (DN). Recently studies sug-
gested that promoting anti-inflammatory M2 macrophage polarization
inhibits renal tubular cell apoptosis in renal ischemia reperfusion injury.
Therefore, we sought to investigate whether calcitriol, known as an impor-
tant renal-protective drug, is sufficient to protect against tubular cell
apoptosis by promoting M2 macrophage in DN rats.
Methods: DN model rats were established by intraperitoneal injection with
streptozocin (STZ). The rats were subsequently receiving either calcitriol
(0.1 mg/kg/d) or vehicle by gavage. Rats were sacrificed at 18w for histolog-
ical and molecular analysis. In addition, we performed in vitro study using
Raw264.7 cells cultured with either high glucose or high glucose followed
by 1,25-dihydroxyvitamin D3 medium to assess macrophage phenotype.
Results: Calcitriol significantly improved renal function and ameliorated
renal histology in DN rats. The increased tubular cell apoptosis in DN rats
was alleviated by calcitriol. Calcitriol up-regulated the expression of anti-
apoptotic protein Bcl-2, and down-regulated the expression of pro-apoptotic
protein such as Bax and caspase-3. Interestingly, calcitriol significantly
enhanced M2 macrophage polarization in interstitium with elevated expres-
sions of M2 markers, including CD163, Arg-1 and MR. Moreover, the ratio of
CD163/CD68 considered as the proportion of M2 macrophage was about
2.9 fold highly after calcitriol treatment.
Diabetic Nephropathy S11Conclusion: Calcitriol protects against renal tubular cell apoptosis by pro-
moting M2 macrophage polarization in STZ-induced DN rats.http://dx.doi.org/10.1016/j.hkjn.2015.08.035
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Objective: Autophagy has been suggested to protect renal tubular epithelial
cells (TECs) from injury during diabetic nephropathy (DN). However, the
manner in which the autophagy-lysosome pathway is changed in this state
remains unclear.
Methods: In this study of DN, we investigated the autophagic activity and
lysosomal alteration in vivo and in vitro.
Results: We found that autophagic vacuoles and SQSTM1 positive proteins
accumulated in TECs from patients with DN and also in HK-2 cells treated
with advanced glycation end products (AGEs), the important factors that
involved in the pathogenesis of DN. In HK-2 cells, exposure to AGEs caused
a significant increase in autophagosomes, but a marked decrease in autoly-
sosomes. Furthermore, the lysosomal turnover of LC3-II was not observed
post AGEs treatment. Furthermore, lysosomal membrane permeabilization
(LMP) was triggered by AGEs during the progression of DN, which likely
resulted in a decrease in the enzymatic activity of cathepsin B (CB) and
CL, the defective acidification of lysosomes, and suppressed the degradation
of DQ-ovalbumin. Additionally, ubiquitinated proteins were co-localized
with SQSTM1 positive puncta and accumulated in HK-2 cells after exposure
to AGEs, indicating blocked degradation of SQSTM1 positive and ubiquiti-
nated aggregates.
Conclusion: Taken together, LMP and lysosomal dysfunction are triggered by
AGEs, which induce autophagic inactivation in TECs from patients with DN.
Disruption of autophagy-lysosome pathway should be focused when studying
the mechanisms underlying DN.http://dx.doi.org/10.1016/j.hkjn.2015.08.036
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Objectives: Cyclin-dependent kinase 5 (Cdk5) has been documented in
podocyte injuries in diabetic nephropathy (DN), however its role in renal
tubular epithelial cells has not been elucidated. This study aims to investi-
gate whether Cdk5 regulates tubulointerstitial fibrosis (TIF) via the extracel-
lular signal-regulated kinase 1/2 (ERK1/2)/peroxisome proliferator-
activated receptor gamma (PPRAg) pathway in DN.
Methods: Effects of activating or inhibiting Cdk5, ERK1/2 and PPARg
signaling on downstream gene expressions and epithelial-to-mesenchymal
transition (EMT) were investigated using in vitro and in vivo approaches. Ex-
pressions of related molecules were validated in 86 archival DN patient renal
biopsy samples and biological parameters were analyzed.
Results: In high glucose cultured normal rat kidney cells (NRK52E) cells, in-
hibition of Cdk5 kinase activity using roscovitine decreased the expression of
mesenchymal markers and the ability of cells to migrate and invade via
ERK1/2/PPARg pathway (Figure 1). In diabetic rat kidneys, inhibition of
Cdk5 kinase activity using roscovitine increased phosphorylation of ERK1/2
and PPARg leading to upregulation of E-cadherin but downregulation of
vimentin and collagen IV and improved TIF. Blood urine nitrogen (BUN),
serum creatinine and b2-microglobulin were decreased. In DN patients’
renal biopsy samples (Figure 2), the expression level of CDK5 and p35
were upregulated with increased phosphorylation of ERK1/2 and PPARg in
the late stage compared with early-stage DN. These changes were concom-
itant with decreased expression of E-cadherin but increased vimentin and
collagen IV with deteriorated TIF and elevated BUN, serum creatinine and
b2-microglobulin.
